New patchoulol- and guaiane-type sesquiterpenoids from Sanguisorba officinalis with anti-melanogenic activity
Natural Products and Bioprospecting · 2026-12 · 16 (1)
DOI: 10.1007/s13659-026-00616-0 ↗Kurz gefasst
Fachartikel in der Zeitschrift Natural Products and Bioprospecting, online erschienen am 12.05.2026. Verfasst von Long-Long Wu und 4 weiteren Autor:innen. Beteiligte Einrichtung: School of Pharmacy, Shanghai University of Traditional Chinese Medicine, Shanghai, 201203, People's Republic of China. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 53 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Natural Science Foundation of China, Shanghai E-research Institute of Bioactive Constituents in Traditional Chinese Medicine.
Abstract (Originalsprache)
Twelve new sesquiterpenoids, sanguisorbaols A–L ( 1–12 ), along with twenty-five known compounds ( 13–37 ), were isolated from the roots of Sanguisorba officinalis . Structures were determined through comprehensive analysis of HRESIMS, 1D and 2D NMR spectroscopic data, ECD and NMR calculations, and X-ray crystallographic analysis. Among them, compounds 1–6 were identified as new patchoulol-type sesquiterpenoids bearing hydroxyl groups at different positions, the further structural elucidation revealed that compounds 5 and 6 are nor-patchoulol-type sesquiterpenoids due to the absence of the C-11 carbon atom. Compounds 7–11 were characterized as guaiane-type sesquiterpenoids incorporating a [5,7]-bicyclic framework, among which 7 and 8 constitute a pair of C-11 epimers. Notably, compound 12 possesses a rare bicyclo[4.3.1]decane core scaffold. All the patchoulol-type sesquiterpenoids reported here were obtained for the first time from the genus Sanguisorba , and a plausible biosynthetic pathway was proposed. Furthermore, the anti-melanogenic bioactivity of all isolates was assessed using IBMX-stimulated B16F10 melanoma cells. Compounds 3–5 , 8–10 , 12–14 , 17 , 19 , 21 , 22 , 25–27 , 29 , 31 , 32 and 34 demonstrated significant inhibitory activity against melanogenesis at concentrations ranging from 6.25 to 50 μM. These results highlighted the potential of S. officinalis as a natural anti-melanogenesis agent for skin-whitening or for the treatment of hyperpigmentation disorders. Graphical Abstract
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- School of Pharmacy, Shanghai University of Traditional Chinese Medicine, Shanghai, 201203, People's Republic of China.
- Institute of Chinese Medicine Resources, Anhui College of Traditional Chinese Medicine, Wuhu, 241000, People's Republic of China.
- School of Pharmacy, Shanghai University of Traditional Chinese Medicine, Shanghai, 201203, People's Republic of China. 04100217@163.com.
- School of Pharmacy, Shanghai University of Traditional Chinese Medicine, Shanghai, 201203, People's Republic of China. ymlius@163.com.
Förderung
- National Natural Science Foundation of China
- Shanghai E-research Institute of Bioactive Constituents in Traditional Chinese Medicine
Zitieren
APA
Wu, L. L., Wu, J. R., Chen, K. X., Zhang, L. Q., & Li, Y. M. (2026). New patchoulol- and guaiane-type sesquiterpenoids from Sanguisorba officinalis with anti-melanogenic activity. Natural Products and Bioprospecting, 16(1). https://doi.org/10.1007/s13659-026-00616-0
Vancouver
Wu LL, Wu JR, Chen KX, Zhang LQ, Li YM. New patchoulol- and guaiane-type sesquiterpenoids from Sanguisorba officinalis with anti-melanogenic activity. Natural Products and Bioprospecting. 2026;16(1). doi:10.1007/s13659-026-00616-0
BibTeX
@article{Wu2026,
author = {Wu, Long-Long and Wu, Jia-Rui and Chen, Kai-Xian and Zhang, Liu-Qiang and Li, Yi-Ming},
title = {New patchoulol- and guaiane-type sesquiterpenoids from Sanguisorba officinalis with anti-melanogenic activity},
journal = {Natural Products and Bioprospecting},
year = {2026},
volume = {16},
number = {1},
doi = {10.1007/s13659-026-00616-0}
}
EUVIMED